MediWound Ltd.

MDWD ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015
Operating Activities
Net Income $-22.1M $-18.9M $-22.1M
Depreciation & Amortization — — —
Depreciation — — —
Amortization — — —
Stock-Based Compensation — — —
Net Cash from Operating Activities $-16.5M $-16.4M $-19.6M
Investing Activities
Capital Expenditures $1.0M $671.0K $376.0K
Business Acquisitions — — —
Net Cash from Investing Activities $437.0K $1.8M $36.0M
Financing Activities
Dividends Paid — — —
Stock Repurchases — — —
Net Cash from Financing Activities $23.0M $907.0K $778.0K
Net Change in Cash $8.8M $-13.6M $17.1M
Free Cash Flow $-17.5M $-17.1M $-20.0M
← Newer Page 2 of 2 Older →